Wenjuan Luo

Qingdao University

Papers

1

Total Citations

4

H-Index

1

About

Wenjuan Luo is an emerging researcher whose work focuses on the intersection of radiation oncology and ocular oncology, with particular expertise in advanced radiotherapy techniques for rare and challenging cancers. Her most notable contribution to date is a systematic review and meta-analysis examining the efficacy and safety of robotic CyberKnife radiotherapy in uveal melanoma — a rare but potentially devastating intraocular malignancy for which treatment options remain limited and technically demanding. Published in 2025, this work represents a meaningful synthesis of clinical evidence in a field where high-quality comparative data is scarce, providing clinicians with critical guidance on the use of stereotactic radiosurgery as a vision- and eye-preserving treatment modality. Having already garnered 4 citations shortly after publication, the research is gaining traction within the oncology community. Luo's rigorous approach to evidence synthesis positions her as a valuable contributor to the growing body of literature on precision radiotherapy for ocular tumors, and her work holds direct implications for improving patient outcomes in uveal melanoma management.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Efficacy and safety of robotic Cyberknife radiotherapy in uveal melanoma: a systematic review and meta-analysis
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 1
🏛 Institutions: Qingdao University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago